Aurobindo Pharma Limited (NSE: AUROPHARMA)

Aurobindo Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	851,426	637,941	303,575	391,729	516,388	242,081
Market Cap Growth	66.03%	110.14%	-22.50%	-24.14%	113.31%	-47.32%
Enterprise Value	854,719	632,994	283,996	394,408	532,915	281,518
Last Close Price	1465.95	1088.75	515.81	655.80	858.85	400.76
PE Ratio	24.39	20.11	15.68	14.51	9.43	8.25
PS Ratio	2.89	2.20	1.22	1.67	2.08	1.05
PB Ratio	2.88	2.14	1.13	1.59	2.35	1.44
P/FCF Ratio	-	-184.48	-1780.50	13.22	27.31	8.07
P/OCF Ratio	-	26.20	12.72	7.81	15.51	5.53
EV/Sales Ratio	2.88	2.18	1.14	1.68	2.15	1.22
EV/EBITDA Ratio	13.64	10.98	7.81	9.15	9.88	5.86
EV/EBIT Ratio	17.93	14.41	11.31	11.93	11.97	7.14
EV/FCF Ratio	-	-183.05	-1665.67	13.31	28.18	9.39
Debt / Equity Ratio	0.22	0.22	0.20	0.12	0.24	0.35
Debt / EBITDA Ratio	1.06	1.14	1.43	0.65	0.97	1.21
Debt / FCF Ratio	-	-19.22	-310.04	0.96	2.82	1.98
Asset Turnover	-	0.68	0.67	0.69	0.79	0.83
Inventory Turnover	-	1.42	1.45	1.26	1.22	1.34
Quick Ratio	-	0.96	0.98	1.10	0.90	0.67
Current Ratio	-	1.98	1.87	2.22	1.86	1.44
Return on Equity (ROE)	-	11.18%	7.50%	11.38%	27.53%	18.52%
Return on Assets (ROA)	-	6.46%	4.25%	6.10%	8.87%	8.89%
Return on Capital (ROIC)	8.71%	8.00%	5.27%	7.56%	11.13%	11.29%
Earnings Yield	4.10%	4.97%	6.35%	6.76%	10.33%	11.75%
FCF Yield	-0.54%	-0.06%	7.57%	3.66%	12.39%
Dividend Yield	0.20%	0.41%	0.58%	1.37%	0.47%	0.75%
Payout Ratio	0.00%	8.31%	22.80%	9.96%	4.39%	6.17%
Buyback Yield / Dilution	-0.00%	-	-	-	-	-0.00%
Total Shareholder Return	0.20%	0.41%	0.58%	1.37%	0.47%	0.75%

Source: S&P Capital IQ. Standard template. Financial Sources.